Clinical significance of sialyl SSEA-1 assay as a tumor marker
Endo, J.; Nagaoka, S.; Kannagi, R.
Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1008-1012
1990
ISSN/ISBN: 0047-1852 PMID: 1972417 Document Number: 354039
Document emailed within 1 workday
Related Documents
Hara, K.; Mitsuhashi, F.; Ohkura, H. 1990: Clinical significance of CA 50 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 971-973Inoue, M.; Shimizu, C.; Sasagawa, T.; Shimizu, H.; Saitoh, J.; Ueda, G.; Tanizawa, O.; Kimura, T.; Kawata, M.; Taniguchi, T. 1987: The clinical value of sialyl SSEA-1 antigen in patients with gynecologic tumors Nihon Sanka Fujinka Gakkai Zasshi 39(12): 2120-2124
Kubota, S. 1990: Clinical significance of polyamine assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 953-956
Kimura, T.; Nawata, H. 1990: Clinical significance of elastase 1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 899-902
Kato, H. 1990: Clinical significance of SCC antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1057-1059
Fujino, M.; Endo, Y. 1990: Clinical significance of carcinoembryonic antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 907-911
Kuriyama, M.; Takahashi, Y.; Kawada, Y. 1990: Clinical significance of prostatic acid phosphatase assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 925-927
Yamano, M. 1990: Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 999-1002
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945
Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T. 1985: Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Oremek, G.; Kukshaĭte, R.; Sapoutzis, N.; Ziolkowski, P. 2007: The significance of TU M2-PK tumor marker for lung cancer diagnostics Klinicheskaia Meditsina 85(7): 56-58
Xie, J.-w.; Huang, C.-m.; Zheng, C.-h.; Li, P.; Wang, J.-b.; Lin, J.-x.; Lu, J. 2013: Expression tumor stem cell surface marker CD44 in gastric cancer and its significance Zhonghua Wei Chang Wai Ke Za Zhi 16(11): 1107-1112
Ke, F.; Wu, J.-M.; Yao, J.-E.; Bai, Y.-J.; Guo, A.-L. 2007: Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis Zhonghua Yi Xue Za Zhi 87(32): 2257-2261
Ogawa, J.; Sano, A.; Koide, S.; Shohtsu, A. 1994: Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl LewisX, and sialyl Lewis(a) in lung cancer Journal of Thoracic and Cardiovascular Surgery 108(2): 329-336
Masuno, T. 1990: Clinical significance of interleukin-4 assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 814-817
Kaku, K.; Harada, Y.; Kaneko, T. 1990: Clinical significance of cyclic GMP assay Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 138-140
Lindmark, G.; Kressner, U.; Bergström, R.; Glimelius, B. 1996: Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer Anticancer Research 16(2): 895-898
Maeda, K.; Chung, Y.S.; Takatsuka, S.; Ogawa, Y.; Onoda, N.; Arimoto, Y.; Nitta, A.; Sawada, T.; Kato, Y.; Sowa, M. 1994: Clinical significance of angiogenesis in gastric carcinoma as a predictive marker for recurrence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(8): 1283-1285
Kärcher, H. 1984: Clinical experiences with the tumor marker TPA in the maxillofacial region Wiener Klinische Wochenschrift 96(19): 732-734